Body

Fibroblasts invade at a snail's pace

A transcription factor known to drive the formation of fibroblasts during development also promotes their ability to invade and remodel surrounding tissues, report Rowe et al. in the February 9, 2009 issue of the Journal of Cell Biology.

Scattered light rapidly detects tumor response to chemotherapy

DURHAM, N.C. -- New technology developed by Duke University bioengineers can help clinicians more precisely detect whether specific cancer drugs are working, and should give basic researchers a powerful new tool to better understand the underlying mechanisms of cancer development.

By interpreting how beams of light scatter off of tumor cell samples, researchers can determine if cancer cells are responding to chemotherapeutic agents within a matter of hours.

New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome

Chemotherapy is an integral part of modern cancer treatment, but it's not always effective. Successful chemotherapy depends on the ability of anticancer drugs to escape from the bloodstream through the leaky blood vessels that often surround tumors.

Predicting chemotherapy's efficacy could save thousands of individuals from unnecessary toxicity and the often difficult side effects of the treatments.

Connectivity illuminates risk of spread of crop pests, diseases

The United States is one of the most important crop production areas in the world, so its vulnerability to crop pests is a vital concern. Ten such pests are estimated to enter the country every year, and the federal government spends more than $1 billion annually on research, emergency response, and education related to crop pests.

Targeted nanospheres find, penetrate, then fuel burning of melanoma

HOUSTON - Hollow gold nanospheres equipped with a targeting peptide find melanoma cells, penetrate them deeply, and then cook the tumor when bathed with near-infrared light, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Feb. 1 issue of Clinical Cancer Research.

New technology discovery at Mount Sinai Hospital holds promise for improved breast cancer treatment

(Toronto, ON, January 29, 2009) – In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options. The tool can predict with more than 80 per cent accuracy a patient's chance of recovering from breast cancer.

Scientists uncover new class of non-protein coding genes in mammals with key functions

A research team at the Broad Institute of Harvard and MIT and Beth Israel Deaconess Medical Center has uncovered a vast new class of previously unrecognized mammalian genes that do not encode proteins, but instead function as long RNA molecules. Their findings, presented in the February 1st advance online issue of the journal Nature, demonstrate that this novel class of "large intervening non-coding RNAs" or "lincRNAs" plays critical roles in both health and disease, including cancer, immune signaling and stem cell biology.

In India: A search for more effective tuberculosis drugs

Rajesh Gokhale has created a compound in his lab in India that stops tuberculosis in its tracks. In a test tube, the molecule hits four of the bacterium's crucial metabolic pathways at the same time, weakening and ultimately destroying the pathogen.

Daytime impairments in older men with obstructive sleep apnea are related to total sleep time

Westchester, Ill. — A study in the Feb. 1 issue of the journal SLEEP shows that daytime functional impairments in older men with obstructive sleep apnea (OSA) are largely explained by total sleep time rather than OSA severity.

Study suggests that inflammation may be the link between extreme sleep durations and poor health

Westchester, Ill. — A study in the Feb. 1 issue of the journal SLEEP shows that sleep duration is associated with changes in the levels of specific cytokines that are important in regulating inflammation. The results suggest that inflammation may be the pathway linking extreme sleep durations to an increased risk for disease.

New screening test can determine whether children have a swallowing disorder

Alexandria, VA – A simple test to swallow three ounces of water can help determine whether a child has the swallowing disorder oropharyngeal dysphagia, establishing for the first time a way to screen for the ailment in children, according to new research published in the February 2009 issue of Otolaryngology – Head and Neck Surgery.

Oropharyngeal dysphagia is a swallowing disorder caused by abnormalities of muscles, nerves, or structures of the oral cavity, pharynx, and upper esophageal sphincter.

Infliximab may help prevent post-operative Crohn's disease recurrence

Bethesda, MD (Feb. 1, 2009) – The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. To date, there have been no randomized controlled trials evaluating infliximab for postoperative Crohn's disease prevention.

Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein

STANFORD, Calif. — Researchers at Stanford University School of Medicine have identified a protein critical for the growth of pancreatic cancer. Blocking the expression of the protein slowed or prevented tumor growth in mice and made cultured cancer cells vulnerable to the conditions of low oxygen that occur in solid tumors.

The American Academy of Periodontology issues statement on periodontal treatment during pregnancy

CHICAGO – January 30, 2009 – Research recently presented at the annual meeting of the Society for Maternal-Fetal Medicine found that routine periodontal treatment in pregnant women did not reduce the risk of preterm deliveries. Some previous studies in this area have suggested that periodontal therapy during pregnancy can lessen the chance of adverse pregnancy outcomes.

'Hot spot' for toxic harmful algal blooms discovered off Washington coast

A part of the Strait of Juan de Fuca, which separates Washington state from Canada's British Columbia, is a potential "hot spot" for toxic harmful algal blooms affecting the Washington and British Columbia coasts.

Marine scientists found that under certain conditions, toxic algal cells from an offshore "initiation site" break off and are transported to nearshore areas, where they may trigger harmful algal blooms that ultimately force the closure of Washington state shellfish beds along beaches.